Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2005
06/01/2005CN1621526A Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof
06/01/2005CN1621525A Gene encoding cellulase of glycosyl hydrolase 9 and use thereof
06/01/2005CN1621524A Prokaryotic expression engineering bacteria for producing human recombinant interleukin-15 and its purifying method
06/01/2005CN1621523A Adenosine phosphate-ribosylation-factor 1 gene in cotton and its promoter
06/01/2005CN1621520A 2-amino phenol 1, 6-dioxygenase, its gene and use thereof
06/01/2005CN1621517A Dunalella salina3-phosphoglycerol dehydrogenase and sequence encoding same
06/01/2005CN1621418A Recombinant targeted toxin against HIV-1
06/01/2005CN1621413A C-type agglutinin and genes encoding same
06/01/2005CN1621412A High molecular wheat glutelin subunit, genes encoding same and use thereof
06/01/2005CN1621411A Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome
06/01/2005CN1621409A Novel growth related genes from swine
06/01/2005CN1621094A Gene transfer for regulating smooth muscle tone
06/01/2005CN1620892A Compound microecological preparation for prawn
06/01/2005CN1204266C Means and method for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
06/01/2005CN1204259C Production process of human lysozyme as AIDS treating medicine with plant as bioreactor
06/01/2005CN1204258C Component of bromelain
06/01/2005CN1204257C New peptide fragments for protein purification
06/01/2005CN1204256C Technology for detecting foot and mouth disease virus antibody of sick livestock using recombination foot and mouth disease vaccine gene expressing protein
06/01/2005CN1204254C Protein DNA whose encoding makes colibacillus possess L-homoserine resistance and method for producing L-amino acid by using the same
06/01/2005CN1204253C Neisseria lactoferrin binding protein
06/01/2005CN1204252C Recombinant gene of soluble part in tumor necrosis factor acceptor and its fusion gene and product
06/01/2005CN1204251C Process for preparing VP2 protein from master host protective antigen (VP2) gene of infections burse disease virus (IBDV) and its gene engineering
06/01/2005CN1204248C Process for preparing target ribonuclease for curing hepatitis B virus infection
06/01/2005CN1204246C Method for forming indoles alkaloid by completely adaptive cell large scale culturing of catharanthus roseus
06/01/2005CN1204147C Method for enhancing circulating half-life of antibody-based fusion proteins
06/01/2005CN1204145C Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment
06/01/2005CN1204142C Antigene V-erb B oligonucleotide and its use
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900371 Pesticidal proteins
05/31/2005US6900370 Generating cell with amplified mutant activity; obtain cell, transform with vector containing nucleotide sequence insert of preferential allele, recover cell and monitor mutational activity
05/31/2005US6900369 Chimera gene coding; transgenic plant
05/31/2005US6900368 Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants
05/31/2005US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye
05/31/2005US6900306 Antisense modulation of CoREST expression
05/31/2005US6900304 Emission ratiometric indicators of phosphorylation
05/31/2005US6900303 57658, a novel human uridine kinase and uses thereof
05/31/2005US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/31/2005US6900300 Quadruplex DNA and duplex probe systems
05/31/2005US6900299 Antisense oligonucleotide inhalant for prevention and treatment of respiratory system disorders; viricides
05/31/2005US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent
05/31/2005US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau
05/31/2005US6900288 Comprises membrane glycoproteins for diagnosis, prevention and treatment of nervous system and cell proliferative disorders
05/31/2005US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
05/31/2005US6900186 Method for the prophylaxis and/or treatment of medical disorders
05/31/2005US6900185 Genetic engineering; binding Dna to apolipoprotein ligand; antitumor agents
05/31/2005US6900053 Antisense modulation of fibroblast growth factor receptor 2 expression
05/31/2005US6900052 Method of culturing cells
05/31/2005US6900049 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
05/31/2005US6900048 Biopolymer arrays and their fabrication
05/31/2005US6900046 Used in therapeutic, diagnostic, and pharmacogenomic applications
05/31/2005US6900045 Nucleotide sequences coding polypeptides for use in human therapeutics, diagnostics and pharmocology
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900038 eNOS mutations useful for gene therapy and therapeutic screening
05/31/2005US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
05/31/2005US6900026 Superoxide dismutase reduced animal model; Parkinson's disease, sepsis, amyotropic lateral sclerosis; prevent free radical damage
05/31/2005US6900025 Detection of antibodies to squalene in serum
05/31/2005US6900022 Prostate cancer-specific marker
05/31/2005US6900018 Method of screening for a biological response using linear and circular expression elements
05/31/2005US6900014 Identifying nucleotide sequences associated with agronomic gene transfer; tissue engineering
05/31/2005US6900012 Plant artificial chromosome compositions and methods
05/31/2005US6899893 Method for treating an allergic or inflammatory disease
05/31/2005US6899884 Vaccine against mumps containing a jeryl-lynn virus strain
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899878 Antibodies to interleukin-1 receptor intracellular ligand proteins
05/31/2005US6899871 Gene delivery system and methods of use
05/31/2005US6899870 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
05/31/2005US6899283 Liquid droplet ejecting method and a liquid droplet ejection apparatus
05/31/2005US6899116 Pressure vessel systems and methods for dispensing liquid chemical compositions
05/31/2005CA2376863C Method and device for applying a plurality of microdroplets onto a substrate
05/31/2005CA2257719C A synthetic plant core promoter and upstream regulatory element
05/31/2005CA2247980C Plastid transformation in arabidopsis thaliana
05/26/2005WO2005047537A2 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
05/26/2005WO2005047518A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
05/26/2005WO2005047517A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
05/26/2005WO2005047516A2 Plant transcriptional regulators
05/26/2005WO2005047515A1 Transgenic disease resistant banana
05/26/2005WO2005047514A1 Proteins involved in signal transduction
05/26/2005WO2005047513A2 Glycin decarboxylase complex as a herbicidal target
05/26/2005WO2005047512A2 Plasmid system for multigene expression
05/26/2005WO2005047511A2 Bacterial expression of protease inhibitors and variants thereof
05/26/2005WO2005047509A2 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
05/26/2005WO2005047507A1 Dna-carrier conjugate
05/26/2005WO2005047506A1 Rna amidates and thioamidates for rnai
05/26/2005WO2005047505A2 Methods and products for expression of micro rnas
05/26/2005WO2005047503A1 Template fixed βετα-hairpin loop mimetics and their use in phage display
05/26/2005WO2005047502A1 Protein library and screening method using the same
05/26/2005WO2005047501A1 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins
05/26/2005WO2005047499A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
05/26/2005WO2005047497A1 High-titer retroviral packaging cells
05/26/2005WO2005047486A2 Biological production of tetradehydrolycopene
05/26/2005WO2005047485A2 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
05/26/2005WO2005047480A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005WO2005047479A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
05/26/2005WO2005047477A2 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
05/26/2005WO2005047473A2 Single vector dual gene therapy for pulmonary hypertension
05/26/2005WO2005047472A2 Increasing seed threonine content through alteration of threonine aldolase activity
05/26/2005WO2005047469A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION